Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Discontinuation due to side effects ran at 7% in Phase 2 data, which is lower than Semaglutides 11% discontinuation rate despite Semaglutide having a higher reported nausea incidence at 44%
On Retatrutide alone, the trial pattern showed appetite suppression appearing within three to four weeks, roughly 8 to 9 percent loss by week 12, climbing toward the high teens by week 24, and approaching the low twenties percent by week 48 in the upper arms
Not for human use, injection, or medical purposes.
US$ 22.91
US$ 22.20
US$ 28.84
US$ 22.99
